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Abstract 
Background The ‘ultra high risk’ criteria identify a clinical population at substantially 
increased risk for progressing to schizophrenia and other psychotic disorders.  While a 
number of clinical variables predictive of transition to psychotic disorder have been identified 
within this population, the predictive value of the level of distress associated with attenuated 
psychotic symptoms has not yet been examined.  This was the aim of the present study. 
Method The level of distress (0-100) associated with attenuated psychotic symptoms was 
recorded for 70 ultra high risk patients using the Comprehensive Assessment of At-Risk 
Mental State (CAARMS).  Transition to psychosis was assessed over a 16-month follow-up 
period.  
Results Of the 70 UHR patients, 15 transitioned to psychosis (21.4%).  Of the 4 CAARMS 
subscales measuring attenuated positive symptoms, Perceptual Abnormalities was rated as 
the most distressing.  There were no differences in CAARMS scales rated as the most 
distressing between those who transitioned to psychosis and those who did not.  There was 
also no association between higher levels of distress associated with attenuated psychotic 
symptoms and transition to psychosis. 
Discussion  While the findings require replication, they indicate that the degree of distress 
associated with attenuated psychotic symptoms should not be used as a criterion for enriching 
UHR samples for risk of frank psychotic disorder.   
 
  
  
Introduction 
The detection of young people who are at heightened risk of developing psychotic disorders 
has significantly improved over the last two decades (1).  This has been facilitated by the 
introduction of the “ultra high risk” (UHR; otherwise known as “clinical high risk” or 
“psychosis high risk”) criteria.  These criteria are based on a combination of state and trait 
risk factors, most prominently attenuated positive psychotic symptoms, in addition to help-
seeking.  A meta-analysis of rates of transition to psychotic disorder in the UHR population 
found a 22% transition rate after 1 year, increasing to 36% after 3 years (2).  Our long term 
follow up study found a 34.9% transition rate over a 2.4-14.9 year follow up period (3).  
These rates are substantially higher than those seen in other clinical populations and in the 
general population. 
 
A challenge has been to identify additional clinical and other predictors (such as 
neurocognitive, neurobiological, and genetic variables) within the UHR population that 
further enhance prediction of outcome.  The clinical variables that have been identified as 
predicting transition to psychosis in UHR samples include: long duration of symptoms prior 
to treatment (3, 4), subthreshold positive symptoms (3-7), poor functioning (3-5, 7, 8), basic 
and negative symptoms (3, 5, 6, 9-11), depression (4, 11), schizotypal disorder (7), sleep 
disturbances (7), substance abuse (12), and genetic risk with functional decline (12).   
 
However, an aspect of this clinical population that has not yet been addressed is the level of 
distress associated with attenuated psychotic symptoms, and whether increased distress in 
relation to these symptoms is associated with increased risk of transition.  This issue is 
significant for several reasons.  Firstly, most UHR patients (approximately 80%) enter clinics 
based on their attenuated psychotic symptoms, rather than one of the other risk groups 
  
(BLIPS or trait vulnerability)(13).  Therefore, improving our understanding of the 
significance of distress associated with these symptoms is important for our understanding of 
the UHR population generally.  Secondly, if higher level of distress associated with 
attenuated psychotic symptoms corresponds to increased risk for transition to psychotic 
disorder then this may assist with “narrowing down” on UHR patients most likely to develop 
psychotic disorder.  This is a salient issue given the decreasing transition rates in more recent 
UHR cohorts (2, 3, 14).  Finally, the description of “Attenuated Psychosis Syndrome” in 
DSM-5, modelled on the UHR criteria, assumes a clinically significant level of distress 
associated with the attenuated psychotic symptoms (“Symptom(s) is sufficiently distressing 
and disabling to the individual to warrant clinical attention”).  However, this has not been 
established in UHR cohorts, who are often in fact referred to clinical services for other, non-
psychotic complaints (15).  
 
In this study, we aimed to examine whether the level of distress associated with attenuated 
psychotic symptoms predicts transition to psychotic disorder in the UHR population. 
 
Method 
Setting 
Orygen Youth Health clinical program (OYH-CP) is a public mental health service for young 
people aged between 15-24 years in the catchment area of western and northwest Melbourne, 
Australia.  The clinical service has four components: EPPIC (Early Psychosis Prevention and 
Intervention Centre, a first episode psychosis service), PACE (Personal Assessment and 
Crisis Evaluation, a UHR clinic), Youth Mood Clinic (a mood disorder clinic), and HYPE 
(Helping Young People Early, a clinic for borderline personality pathology).  Referrals to 
  
OYH-CP are received from a range of sources including school counselors, GPs, other 
healthcare providers, family, friends, and young people themselves.  Individuals referred to 
OYH-CP are assessed at a central triage point, which directs patients to the appropriate clinic.  
Individuals referred to PACE from triage then undergo an entry assessment, at which stage 
the Comprehensive Assessment of At Risk Mental States (CAARMS) is administered to 
assess UHR status.  The CAARMS is administered by trained clinicians – either psychiatrists, 
psychologists or other allied health staff.    
 
Participants 
The recruitment period was 20/5/2006-21/6/2009.  Over this period, the PACE clinic 
received 340 referrals, of which 311 were accepted into the clinic.  Of this cohort, CAARMS 
and distress data were available on 70 cases.  Inclusion criteria were: being aged between 15 
and 24 years, living in the OYH catchment area, and meeting UHR criteria(4).  Exclusion 
criteria were: previous diagnosis of a psychotic disorder, known organic cause of symptoms, 
or if relevant data were not available.  
 
Assessments 
The CAARMS consists of four attenuated positive psychotic symptoms sub-scales: Unusual 
Thought Content (UTC), Non-Bizarre Ideas (NBI), Perceptual Abnormalities (PA), and 
Disorganised Speech (DS).  Each of these are rated on a 0-6 scale for intensity and frequency.  
In addition to this rating, participants were also rated on how distressed they were by these 
attenuated psychotic symptoms.  This was established in the course of the CAARMS semi-
structured interview.  Distress was measured using a Likert scale from 0 (not at all distressed) 
to 100 (extremely distressed).  If the participant rated on multiple attenuated psychotic 
symptoms the highest distress rating was used in data analysis.  Baseline functioning was 
  
assessed using the Global Assessment of Functioning (GAF).  Participants were treated at the 
PACE clinic for approximately one year.  They were regularly monitored by their treating 
psychiatrist and case manager for onset of psychotic disorder.  This is defined as per previous 
research as clear full-threshold positive psychotic symptoms for longer than one week.   
 
Data Analysis 
Statistical analyses were conducted using the statistical package IBM SPSS for Windows, 
version 22.0.  An alpha level of <0.05 was set.  Cox regression was used to assess the 
association between distress rating (0-100) and time to transition.  The cox regression 
adjusted for GAF score as poor functioning as previously been found to predict transition to 
psychosis.   
 
Results 
Baseline characteristics 
Sample characteristics are presented in Table 1. There were no differences in gender or age 
between the cohort and PACE patients who did not have the required data available (n=241).  
 
Insert Table 1 about here 
 
Transition to psychosis  
Transition to psychosis data were available for the full cohort.  Fourteen participants 
transitioned to psychosis within 12 months, and an additional individual transitioned within 
16 months, yielding an overall transition rate of 21.4%.   
 
 
  
Distress in relation to transition  
Cox regression, adjusting for GAF score, indicated that level of distress in relation to 
attenuated psychotic symptoms did not predict transition to psychosis (beta=-.002, SE=.013, 
p=.904).  
 
Distress in relation to type of attenuated psychotic symptom 
An exploratory analysis was conducted to assess if higher distress ratings associated with 
type of attenuated psychotic symptom (UTC, NBI, PA, DS) was associated with transition to 
psychosis.  PA were rated as the most distressing (n=32, 46%) and more frequent PA showed 
a weak but significant correlation with higher distress (r=.26, p=0.03).  NBI were the second 
most distressing (n=21, 30%), followed by UTC (n=14, 20%), and DS (n=3, 4%).  A cox 
regression adjusting for GAF score indicated that higher distress associated with type of 
attenuated psychotic symptoms, using UTC as the reference, did not predict transition 
(p=.853). 
 
Discussion 
To the best of our knowledge, this is the first study to address the level of distress in relation 
to attenuated psychotic symptoms and risk for transition to psychosis in a UHR sample.  
There was no association between level of distress in relation to attenuated psychotic 
symptoms and transition to psychosis.  Perceptual abnormalities were the most distressing, 
with more frequent perceptual abnormalities correlating with higher distress, and 
disorganised speech the least distressing attenuated psychotic symptom.  There was no 
relationship between higher levels of distress in relation to particular types of attenuated 
psychotic symptoms and transition to psychosis.  
 
  
These results provide preliminary evidence that distress in relation to attenuated psychotic 
symptoms is not a good indicator of risk for subsequent psychotic disorder in UHR patients.  
This suggests that help-seeking UHR young people who are not significantly distressed by 
their attenuated psychotic symptoms are just as likely to develop first episode psychosis as 
those who are significantly distressed by these symptoms, and therefore should receive 
clinical care and be recruited to UHR research studies.  
  
Although this issue has not previously been examined in UHR cohorts, the results are 
somewhat at odds with data from a large Dutch general population study (16).  In the 
NEMISIS study 8% of the cohort who had an incident psychotic experience had a subclinical 
outcome two years later, and 8% had a psychotic clinical outcome two years later.  Emotional 
appraisal and degree of intrusiveness of the psychotic experience, which may index level of 
distress, were strong modifiers of the clinical outcome, but not the subclinical outcome.  The 
current data are also not consistent with cognitive models of psychosis that posit that 
interpreting anomalous perceptual or cognitive experiences in an anxiety or distress-
provoking manner may exacerbate psychotic symptoms (17, 18). 
 
Recent evidence indicates that only 52% of UHR patients find their attenuated psychotic 
symptoms distressing, with social and functioning difficulties and depressive symptoms 
being the most prominent sources of distress in this population (19).  Thus the distress and 
help-seeking in this population is attributable to a wide range of reasons, rather than being 
solely attributable to attenuated psychotic symptoms.  This suggests that the requirement in 
the DSM-V Attenuated Psychosis Syndrome that the attenuated psychotic symptoms are 
“sufficiently distressing and disabling to warrant clinical attention” would identify a 
  
significantly different group than that which is currently recruited in UHR studies.  The 
finding that a higher level of distress associated with attenuated psychotic symptoms is not 
associated with a higher risk for psychosis also suggests that this criterion for Attenuated 
Psychosis Syndrome would not identify a group at enriched risk for psychotic disorder. 
 
The current study suffers from a number of limitations.  The sample with available data was a 
subset of the overall sample of UHR patients seen over the recruitment period.  While the 
demographic data indicate that this sub-set was representative of the age and gender of the 
overall pool of patients, it is possible that the larger pool of patients may have differed on 
other variables not captured, possibly resulting in a selection bias.  Second, the type of 
treatment that the UHR patients received was not taken into account in analysis.  The 
particular type of treatment, for example cognitive-behaviour therapy directed towards 
reducing distress associated with attenuated psychotic symptoms, may have moderated the 
risk for transition to psychotic disorder.  Finally, distress was measured as a single 
“snapshot” at entry to the clinic.  This measurement may have been influenced by factors 
such as self-stigma, shame associated with symptoms, patients’ coping style, sufficient 
rapport and engagement not yet established with the clinical team, and so on.  Future work 
may wish to adopt a more thorough approach to measuring distress associated with 
symptoms.  
 
Conclusion 
These findings indicate that perceptual abnormalities are the attenuated positive psychotic 
symptoms most distressing to UHR patients at entry.  Higher levels of distress associated 
with symptoms is not associated with transition to psychotic disorder over the subsequent 1.5 
years.  While the findings require replication, they indicate that the degree of distress 
  
associated with attenuated psychotic symptoms should not be used as a criterion for enriching 
UHR samples for risk of frank psychotic disorder. 
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